 | • レポートコード：MRC2102QY7521 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、139ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界の便秘薬による過敏性腸症候群市場について種類別（ルビプロストン、リナクロチド、覚醒剤下剤、浸透圧性下剤、その他）、用途別（病院、診療所、その他）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・便秘薬による過敏性腸症候群市場の概要 ・世界の主要地域別便秘薬による過敏性腸症候群市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の便秘薬による過敏性腸症候群市場規模2015-2026：種類別（ルビプロストン、リナクロチド、覚醒剤下剤、浸透圧性下剤、その他） ・世界の便秘薬による過敏性腸症候群市場規模2015-2026：用途別（病院、診療所、その他） ・便秘薬による過敏性腸症候群の米国市場規模2015-2020 ・便秘薬による過敏性腸症候群のヨーロッパ市場規模2015-2020 ・便秘薬による過敏性腸症候群の中国市場規模2015-2020 ・便秘薬による過敏性腸症候群の日本市場規模2015-2020 ・便秘薬による過敏性腸症候群の東南アジア市場規模2015-2020 ・便秘薬による過敏性腸症候群のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・便秘薬による過敏性腸症候群の製造コスト分析 ・販売チャネル、流通業者、顧客 ・便秘薬による過敏性腸症候群の市場動向・機会・課題 ・調査の結論 |
The symptoms of IBS-C include abdominal pain and discomfort, along with changes in bowel function. Bloating and/or gas also may happen. Changes in bowel function may include straining, infrequent stools, hard or lumpy stools, and/or a feeling that the bowel does not empty completely.
Market Analysis and Insights: Global Irritable Bowel Syndrome with Constipation Drugs Market
The global Irritable Bowel Syndrome with Constipation Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
Global Irritable Bowel Syndrome with Constipation Drugs Scope and Market Size
The global Irritable Bowel Syndrome with Constipation Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Irritable Bowel Syndrome with Constipation Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Irritable Bowel Syndrome with Constipation Drugs market is segmented into
Lubiprostone
Linaclotide
Stimulant Laxatives
Osmotic Laxatives
Others
Segment by Application, the Irritable Bowel Syndrome with Constipation Drugs market is segmented into
Hospitals
Clinics
Others
The Irritable Bowel Syndrome with Constipation Drugs market is analysed and market size information is provided by regions (countries). Segment by Application, the Irritable Bowel Syndrome with Constipation Drugs market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Irritable Bowel Syndrome with Constipation Drugs Market Share Analysis
Irritable Bowel Syndrome with Constipation Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Irritable Bowel Syndrome with Constipation Drugs business, the date to enter into the Irritable Bowel Syndrome with Constipation Drugs market, Irritable Bowel Syndrome with Constipation Drugs product introduction, recent developments, etc.
The major vendors covered:
Nestle
Abbot Laboratories
Synergy Pharmaceuticals
Sucampo Pharmaceuticals
Novartis
Astellas Pharmaceuticals
1 Irritable Bowel Syndrome with Constipation Drugs Market Overview
1.1 Irritable Bowel Syndrome with Constipation Drugs Product Scope
1.2 Irritable Bowel Syndrome with Constipation Drugs Segment by Type
1.2.1 Global Irritable Bowel Syndrome with Constipation Drugs Sales by Type (2020-2026)
1.2.2 Lubiprostone
1.2.3 Linaclotide
1.2.4 Stimulant Laxatives
1.2.5 Osmotic Laxatives
1.2.6 Others
1.3 Irritable Bowel Syndrome with Constipation Drugs Segment by Application
1.3.1 Global Irritable Bowel Syndrome with Constipation Drugs Sales Comparison by Application (2020-2026)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Irritable Bowel Syndrome with Constipation Drugs Market Estimates and Forecasts (2015-2026)
1.4.1 Global Irritable Bowel Syndrome with Constipation Drugs Sales Growth Rate (2015-2026)
1.4.2 Global Irritable Bowel Syndrome with Constipation Drugs Revenue and Growth Rate (2015-2026)
1.4.3 Global Irritable Bowel Syndrome with Constipation Drugs Price Trends (2015-2026)
2 Irritable Bowel Syndrome with Constipation Drugs Estimate and Forecast by Region
2.1 Global Irritable Bowel Syndrome with Constipation Drugs Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Irritable Bowel Syndrome with Constipation Drugs Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Irritable Bowel Syndrome with Constipation Drugs Sales Market Share by Region (2015-2020)
2.2.2 Global Irritable Bowel Syndrome with Constipation Drugs Revenue Market Share by Region (2015-2020)
2.3 Global Irritable Bowel Syndrome with Constipation Drugs Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Irritable Bowel Syndrome with Constipation Drugs Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Irritable Bowel Syndrome with Constipation Drugs Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Irritable Bowel Syndrome with Constipation Drugs Estimates and Projections (2015-2026)
2.4.2 Europe Irritable Bowel Syndrome with Constipation Drugs Estimates and Projections (2015-2026)
2.4.3 China Irritable Bowel Syndrome with Constipation Drugs Estimates and Projections (2015-2026)
2.4.4 Japan Irritable Bowel Syndrome with Constipation Drugs Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Irritable Bowel Syndrome with Constipation Drugs Estimates and Projections (2015-2026)
2.4.6 India Irritable Bowel Syndrome with Constipation Drugs Estimates and Projections (2015-2026)
3 Global Irritable Bowel Syndrome with Constipation Drugs Competition Landscape by Players
3.1 Global Top Irritable Bowel Syndrome with Constipation Drugs Players by Sales (2015-2020)
3.2 Global Top Irritable Bowel Syndrome with Constipation Drugs Players by Revenue (2015-2020)
3.3 Global Irritable Bowel Syndrome with Constipation Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Irritable Bowel Syndrome with Constipation Drugs as of 2019)
3.4 Global Irritable Bowel Syndrome with Constipation Drugs Average Price by Company (2015-2020)
3.5 Manufacturers Irritable Bowel Syndrome with Constipation Drugs Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Irritable Bowel Syndrome with Constipation Drugs Players (Opinion Leaders)
4 Global Irritable Bowel Syndrome with Constipation Drugs Market Size by Type
4.1 Global Irritable Bowel Syndrome with Constipation Drugs Historic Market Review by Type (2015-2020)
4.1.1 Global Irritable Bowel Syndrome with Constipation Drugs Sales Market Share by Type (2015-2020)
4.1.2 Global Irritable Bowel Syndrome with Constipation Drugs Revenue Market Share by Type (2015-2020)
4.1.3 Global Irritable Bowel Syndrome with Constipation Drugs Price by Type (2015-2020)
4.2 Global Irritable Bowel Syndrome with Constipation Drugs Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Irritable Bowel Syndrome with Constipation Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Irritable Bowel Syndrome with Constipation Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Global Irritable Bowel Syndrome with Constipation Drugs Price Forecast by Type (2021-2026)
5 Global Irritable Bowel Syndrome with Constipation Drugs Market Size by Application
5.1 Global Irritable Bowel Syndrome with Constipation Drugs Historic Market Review by Application (2015-2020)
5.1.1 Global Irritable Bowel Syndrome with Constipation Drugs Sales Market Share by Application (2015-2020)
5.1.2 Global Irritable Bowel Syndrome with Constipation Drugs Revenue Market Share by Application (2015-2020)
5.1.3 Global Irritable Bowel Syndrome with Constipation Drugs Price by Application (2015-2020)
5.2 Global Irritable Bowel Syndrome with Constipation Drugs Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Irritable Bowel Syndrome with Constipation Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Irritable Bowel Syndrome with Constipation Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Irritable Bowel Syndrome with Constipation Drugs Price Forecast by Application (2021-2026)
6 United States Irritable Bowel Syndrome with Constipation Drugs Market Facts & Figures
6.1 United States Irritable Bowel Syndrome with Constipation Drugs Sales Market Share by Company (2015-2020)
6.2 United States Irritable Bowel Syndrome with Constipation Drugs Sales Market Share by Type (2015-2020)
6.3 United States Irritable Bowel Syndrome with Constipation Drugs Sales Market Share by Application (2015-2020)
7 Europe Irritable Bowel Syndrome with Constipation Drugs Market Facts & Figures
7.1 Europe Irritable Bowel Syndrome with Constipation Drugs Sales Market Share by Company (2015-2020)
7.2 Europe Irritable Bowel Syndrome with Constipation Drugs Sales Market Share by Type (2015-2020)
7.3 Europe Irritable Bowel Syndrome with Constipation Drugs Sales Market Share by Application (2015-2020)
8 China Irritable Bowel Syndrome with Constipation Drugs Market Facts & Figures
8.1 China Irritable Bowel Syndrome with Constipation Drugs Sales Market Share by Company (2015-2020)
8.2 China Irritable Bowel Syndrome with Constipation Drugs Sales Market Share by Type (2015-2020)
8.3 China Irritable Bowel Syndrome with Constipation Drugs Sales Market Share by Application (2015-2020)
9 Japan Irritable Bowel Syndrome with Constipation Drugs Market Facts & Figures
9.1 Japan Irritable Bowel Syndrome with Constipation Drugs Sales Market Share by Company (3015-3030)
9.2 Japan Irritable Bowel Syndrome with Constipation Drugs Sales Market Share by Type (2015-2020)
9.3 Japan Irritable Bowel Syndrome with Constipation Drugs Sales Market Share by Application (2015-2020)
10 Southeast Asia Irritable Bowel Syndrome with Constipation Drugs Market Facts & Figures
10.1 Southeast Asia Irritable Bowel Syndrome with Constipation Drugs Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Irritable Bowel Syndrome with Constipation Drugs Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Irritable Bowel Syndrome with Constipation Drugs Sales Market Share by Application (2015-2020)
11 India Irritable Bowel Syndrome with Constipation Drugs Market Facts & Figures
11.1 India Irritable Bowel Syndrome with Constipation Drugs Sales Market Share by Company (2015-2020)
11.2 India Irritable Bowel Syndrome with Constipation Drugs Sales Market Share by Type (2015-2020)
11.3 India Irritable Bowel Syndrome with Constipation Drugs Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Irritable Bowel Syndrome with Constipation Drugs Business
12.1 Nestle
12.1.1 Nestle Corporation Information
12.1.2 Nestle Business Overview
12.1.3 Nestle Irritable Bowel Syndrome with Constipation Drugs Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Nestle Irritable Bowel Syndrome with Constipation Drugs Products Offered
12.1.5 Nestle Recent Development
12.2 Abbot Laboratories
12.2.1 Abbot Laboratories Corporation Information
12.2.2 Abbot Laboratories Business Overview
12.2.3 Abbot Laboratories Irritable Bowel Syndrome with Constipation Drugs Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Abbot Laboratories Irritable Bowel Syndrome with Constipation Drugs Products Offered
12.2.5 Abbot Laboratories Recent Development
12.3 Synergy Pharmaceuticals
12.3.1 Synergy Pharmaceuticals Corporation Information
12.3.2 Synergy Pharmaceuticals Business Overview
12.3.3 Synergy Pharmaceuticals Irritable Bowel Syndrome with Constipation Drugs Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Synergy Pharmaceuticals Irritable Bowel Syndrome with Constipation Drugs Products Offered
12.3.5 Synergy Pharmaceuticals Recent Development
12.4 Sucampo Pharmaceuticals
12.4.1 Sucampo Pharmaceuticals Corporation Information
12.4.2 Sucampo Pharmaceuticals Business Overview
12.4.3 Sucampo Pharmaceuticals Irritable Bowel Syndrome with Constipation Drugs Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Sucampo Pharmaceuticals Irritable Bowel Syndrome with Constipation Drugs Products Offered
12.4.5 Sucampo Pharmaceuticals Recent Development
12.5 Novartis
12.5.1 Novartis Corporation Information
12.5.2 Novartis Business Overview
12.5.3 Novartis Irritable Bowel Syndrome with Constipation Drugs Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Novartis Irritable Bowel Syndrome with Constipation Drugs Products Offered
12.5.5 Novartis Recent Development
12.6 Astellas Pharmaceuticals
12.6.1 Astellas Pharmaceuticals Corporation Information
12.6.2 Astellas Pharmaceuticals Business Overview
12.6.3 Astellas Pharmaceuticals Irritable Bowel Syndrome with Constipation Drugs Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Astellas Pharmaceuticals Irritable Bowel Syndrome with Constipation Drugs Products Offered
12.6.5 Astellas Pharmaceuticals Recent Development
…
13 Irritable Bowel Syndrome with Constipation Drugs Manufacturing Cost Analysis
13.1 Irritable Bowel Syndrome with Constipation Drugs Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Irritable Bowel Syndrome with Constipation Drugs
13.4 Irritable Bowel Syndrome with Constipation Drugs Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Irritable Bowel Syndrome with Constipation Drugs Distributors List
14.3 Irritable Bowel Syndrome with Constipation Drugs Customers
15 Market Dynamics
15.1 Irritable Bowel Syndrome with Constipation Drugs Market Trends
15.2 Irritable Bowel Syndrome with Constipation Drugs Opportunities and Drivers
15.3 Irritable Bowel Syndrome with Constipation Drugs Market Challenges
15.4 Irritable Bowel Syndrome with Constipation Drugs Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Irritable Bowel Syndrome with Constipation Drugs Sales (K MT) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Irritable Bowel Syndrome with Constipation Drugs Sales (K MT) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Irritable Bowel Syndrome with Constipation Drugs Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Irritable Bowel Syndrome with Constipation Drugs Sales (K MT) by Region (2015-2020)
Table 5. Global Irritable Bowel Syndrome with Constipation Drugs Sales Market Share by Region (2015-2020)
Table 6. Global Irritable Bowel Syndrome with Constipation Drugs Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Irritable Bowel Syndrome with Constipation Drugs Revenue Share by Region (2015-2020)
Table 8. Global Irritable Bowel Syndrome with Constipation Drugs Sales (K MT) Forecast by Region (2021-2026)
Table 9. Global Irritable Bowel Syndrome with Constipation Drugs Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Irritable Bowel Syndrome with Constipation Drugs Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Irritable Bowel Syndrome with Constipation Drugs Revenue Share Forecast by Region (2021-2026)
Table 12. Global Irritable Bowel Syndrome with Constipation Drugs (K MT) of Key Companies (2015-2020)
Table 13. Global Irritable Bowel Syndrome with Constipation Drugs Sales Share by Company (2015-2020)
Table 14. Global Irritable Bowel Syndrome with Constipation Drugs Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Irritable Bowel Syndrome with Constipation Drugs Revenue Share by Company (2015-2020)
Table 16. Global Irritable Bowel Syndrome with Constipation Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Irritable Bowel Syndrome with Constipation Drugs as of 2019)
Table 17. Global Irritable Bowel Syndrome with Constipation Drugs Average Price (USD/MT) of Key Company (2015-2020)
Table 18. Manufacturers Irritable Bowel Syndrome with Constipation Drugs Manufacturing Sites and Area Served
Table 19. Manufacturers Irritable Bowel Syndrome with Constipation Drugs Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Irritable Bowel Syndrome with Constipation Drugs Players
Table 22. Global Irritable Bowel Syndrome with Constipation Drugs Sales (K MT) by Type (2015-2020)
Table 23. Global Irritable Bowel Syndrome with Constipation Drugs Sales Share by Type (2015-2020)
Table 24. Global Irritable Bowel Syndrome with Constipation Drugs Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Irritable Bowel Syndrome with Constipation Drugs Price (K MT) by Type (2015-2020)
Table 26. Global Irritable Bowel Syndrome with Constipation Drugs Sales Share by Type (2021-2026)
Table 27. Global Irritable Bowel Syndrome with Constipation Drugs Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Irritable Bowel Syndrome with Constipation Drugs Revenue Share by Type (2021-2026)
Table 29. Global Irritable Bowel Syndrome with Constipation Drugs Price (K MT) by Type (2021-2026)
Table 30. Global Irritable Bowel Syndrome with Constipation Drugs Sales (K MT) by Application (2015-2020)
Table 31. Global Irritable Bowel Syndrome with Constipation Drugs Sales Share by Application (2015-2020)
Table 32. Global Irritable Bowel Syndrome with Constipation Drugs Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Irritable Bowel Syndrome with Constipation Drugs Price (K MT) by Application (2015-2020)
Table 34. Global Irritable Bowel Syndrome with Constipation Drugs Sales (K MT) by Application (2021-2026)
Table 35. Global Irritable Bowel Syndrome with Constipation Drugs Sales Share by Application (2021-2026)
Table 36. Global Irritable Bowel Syndrome with Constipation Drugs Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Irritable Bowel Syndrome with Constipation Drugs Revenue Share by Application (2021-2026)
Table 38. Global Irritable Bowel Syndrome with Constipation Drugs Price (K MT) by Application (2021-2026)
Table 39. United States Irritable Bowel Syndrome with Constipation Drugs Sales (K MT) by Company (2015-2020)
Table 40. United States Irritable Bowel Syndrome with Constipation Drugs Sales Market Share by Company (2015-2020)
Table 41. United States Irritable Bowel Syndrome with Constipation Drugs Sales (K MT) by Type (2015-2020)
Table 42. United States Irritable Bowel Syndrome with Constipation Drugs Sales Market Share by Type (2015-2020)
Table 43. United States Irritable Bowel Syndrome with Constipation Drugs Sales (K MT) by Application (2015-2020)
Table 44. United States Irritable Bowel Syndrome with Constipation Drugs Sales Market Share by Application (2015-2020)
Table 45. Europe Irritable Bowel Syndrome with Constipation Drugs Sales (K MT) by Company (2015-2020)
Table 46. Europe Irritable Bowel Syndrome with Constipation Drugs Sales Market Share by Company (2015-2020)
Table 47. Europe Irritable Bowel Syndrome with Constipation Drugs Sales (K MT) by Type (2015-2020)
Table 48. Europe Irritable Bowel Syndrome with Constipation Drugs Sales Market Share by Type (2015-2020)
Table 49. Europe Irritable Bowel Syndrome with Constipation Drugs Sales (K MT) by Application (2015-2020)
Table 50. Europe Irritable Bowel Syndrome with Constipation Drugs Sales Market Share by Type (2015-2020)
Table 51. China Irritable Bowel Syndrome with Constipation Drugs Sales (K MT) by Company (2015-2020)
Table 52. China Irritable Bowel Syndrome with Constipation Drugs Sales Market Share by Company (2015-2020)
Table 53. China Irritable Bowel Syndrome with Constipation Drugs Sales (K MT) by Type (2015-2020)
Table 54. China Irritable Bowel Syndrome with Constipation Drugs Sales Market Share by Type (2015-2020)
Table 55. China Irritable Bowel Syndrome with Constipation Drugs Sales (K MT) by Application (2015-2020)
Table 56. China Irritable Bowel Syndrome with Constipation Drugs Sales Market Share by Application (2015-2020)
Table 57. Japan Irritable Bowel Syndrome with Constipation Drugs Sales (K MT) by Company (2015-2020)
Table 58. Japan Irritable Bowel Syndrome with Constipation Drugs Sales Market Share by Company (2015-2020)
Table 59. Japan Irritable Bowel Syndrome with Constipation Drugs Sales (K MT) by Type (2015-2020)
Table 60. Japan Irritable Bowel Syndrome with Constipation Drugs Sales Market Share by Type (2015-2020)
Table 61. Japan Irritable Bowel Syndrome with Constipation Drugs Sales (K MT) by Application (2015-2020)
Table 62. Japan Irritable Bowel Syndrome with Constipation Drugs Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Irritable Bowel Syndrome with Constipation Drugs Sales (K MT) by Company (2015-2020)
Table 64. Southeast Asia Irritable Bowel Syndrome with Constipation Drugs Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Irritable Bowel Syndrome with Constipation Drugs Sales (K MT) by Type (2015-2020)
Table 66. Southeast Asia Irritable Bowel Syndrome with Constipation Drugs Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Irritable Bowel Syndrome with Constipation Drugs Sales (K MT) by Type (2015-2020)
Table 68. Southeast Asia Irritable Bowel Syndrome with Constipation Drugs Sales Market Share by Application (2015-2020)
Table 69. India Irritable Bowel Syndrome with Constipation Drugs Sales (K MT) by Company (2015-2020)
Table 70. India Irritable Bowel Syndrome with Constipation Drugs Sales Market Share by Company (2015-2020)
Table 71. India Irritable Bowel Syndrome with Constipation Drugs Sales (K MT) by Type (2015-2020)
Table 72. India Irritable Bowel Syndrome with Constipation Drugs Sales Market Share by Type (2015-2020)
Table 73. India Irritable Bowel Syndrome with Constipation Drugs Sales (K MT) by Application (2015-2020)
Table 74. India Irritable Bowel Syndrome with Constipation Drugs Sales Market Share by Application (2015-2020)
Table 75. Nestle Corporation Information
Table 76. Nestle Description and Business Overview
Table 77. Nestle Irritable Bowel Syndrome with Constipation Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. Nestle Irritable Bowel Syndrome with Constipation Drugs Product
Table 79. Nestle Recent Development
Table 80. Abbot Laboratories Corporation Information
Table 81. Abbot Laboratories Description and Business Overview
Table 82. Abbot Laboratories Irritable Bowel Syndrome with Constipation Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. Abbot Laboratories Irritable Bowel Syndrome with Constipation Drugs Product
Table 84. Abbot Laboratories Recent Development
Table 85. Synergy Pharmaceuticals Corporation Information
Table 86. Synergy Pharmaceuticals Description and Business Overview
Table 87. Synergy Pharmaceuticals Irritable Bowel Syndrome with Constipation Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Synergy Pharmaceuticals Irritable Bowel Syndrome with Constipation Drugs Product
Table 89. Synergy Pharmaceuticals Recent Development
Table 90. Sucampo Pharmaceuticals Corporation Information
Table 91. Sucampo Pharmaceuticals Description and Business Overview
Table 92. Sucampo Pharmaceuticals Irritable Bowel Syndrome with Constipation Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Sucampo Pharmaceuticals Irritable Bowel Syndrome with Constipation Drugs Product
Table 94. Sucampo Pharmaceuticals Recent Development
Table 95. Novartis Corporation Information
Table 96. Novartis Description and Business Overview
Table 97. Novartis Irritable Bowel Syndrome with Constipation Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. Novartis Irritable Bowel Syndrome with Constipation Drugs Product
Table 99. Novartis Recent Development
Table 100. Astellas Pharmaceuticals Corporation Information
Table 101. Astellas Pharmaceuticals Description and Business Overview
Table 102. Astellas Pharmaceuticals Irritable Bowel Syndrome with Constipation Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. Astellas Pharmaceuticals Irritable Bowel Syndrome with Constipation Drugs Product
Table 104. Astellas Pharmaceuticals Recent Development
Table 105. Production Base and Market Concentration Rate of Raw Material
Table 106. Key Suppliers of Raw Materials
Table 107. Irritable Bowel Syndrome with Constipation Drugs Distributors List
Table 108. Irritable Bowel Syndrome with Constipation Drugs Customers List
Table 109. Irritable Bowel Syndrome with Constipation Drugs Market Key Trends
Table 110. Irritable Bowel Syndrome with Constipation Drugs Key Opportunities and Drivers
Table 111. Irritable Bowel Syndrome with Constipation Drugs Market Challenges
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Irritable Bowel Syndrome with Constipation Drugs Product Picture
Figure 2. Global Irritable Bowel Syndrome with Constipation Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Irritable Bowel Syndrome with Constipation Drugs Market Share by Application in 2020 & 2026
Figure 6. Hospitals Examples
Figure 7. Clinics Examples
Figure 8. Others Examples
Figure 9. Global Irritable Bowel Syndrome with Constipation Drugs Sales (K MT) Growth Rate (2015-2026)
Figure 10. Global Irritable Bowel Syndrome with Constipation Drugs Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Irritable Bowel Syndrome with Constipation Drugs Price Trends Growth Rate (2015-2026) (USD/MT)
Figure 12. Global Irritable Bowel Syndrome with Constipation Drugs Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Irritable Bowel Syndrome with Constipation Drugs Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Irritable Bowel Syndrome with Constipation Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Irritable Bowel Syndrome with Constipation Drugs Sales (K MT) Growth Rate (2015-2026)
Figure 16. Europe Irritable Bowel Syndrome with Constipation Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Irritable Bowel Syndrome with Constipation Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Irritable Bowel Syndrome with Constipation Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Irritable Bowel Syndrome with Constipation Drugs Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Irritable Bowel Syndrome with Constipation Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Irritable Bowel Syndrome with Constipation Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Irritable Bowel Syndrome with Constipation Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Irritable Bowel Syndrome with Constipation Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Irritable Bowel Syndrome with Constipation Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Irritable Bowel Syndrome with Constipation Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Irritable Bowel Syndrome with Constipation Drugs Players Market Share by Revenue in Irritable Bowel Syndrome with Constipation Drugs 2015 & 2019
Figure 27. Irritable Bowel Syndrome with Constipation Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Irritable Bowel Syndrome with Constipation Drugs Revenue Share by Type (2015-2020)
Figure 29. Global Irritable Bowel Syndrome with Constipation Drugs Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Irritable Bowel Syndrome with Constipation Drugs Revenue Share by Application (2015-2020)
Figure 31. Global Irritable Bowel Syndrome with Constipation Drugs Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Irritable Bowel Syndrome with Constipation Drugs Sales Market Share by Type in 2019
Figure 33. United States Irritable Bowel Syndrome with Constipation Drugs Sales Market Share by Type in 2019
Figure 34. Europe Irritable Bowel Syndrome with Constipation Drugs Sales Market Share by Company in 2019
Figure 35. Europe Irritable Bowel Syndrome with Constipation Drugs Sales Market Share by Type in 2019
Figure 36. Europe Irritable Bowel Syndrome with Constipation Drugs Sales Market Share by Application in 2019
Figure 37. China Irritable Bowel Syndrome with Constipation Drugs Sales Market Share by Company in 2019
Figure 38. China Irritable Bowel Syndrome with Constipation Drugs Sales Market Share by Type in 2019
Figure 39. China Irritable Bowel Syndrome with Constipation Drugs Sales Market Share by Application in 2019
Figure 40. Japan Irritable Bowel Syndrome with Constipation Drugs Sales Market Share by Company in 2019
Figure 41. Japan Irritable Bowel Syndrome with Constipation Drugs Sales Market Share by Type in 2019
Figure 42. Japan Irritable Bowel Syndrome with Constipation Drugs Sales Market Share by Application in 2019
Figure 43. Southeast Asia Irritable Bowel Syndrome with Constipation Drugs Sales Market Share by Company in 2019
Figure 44. Southeast Asia Irritable Bowel Syndrome with Constipation Drugs Sales Market Share by Type in 2019
Figure 45. Southeast Asia Irritable Bowel Syndrome with Constipation Drugs Sales Market Share by Application in 2019
Figure 46. India Irritable Bowel Syndrome with Constipation Drugs Sales Market Share by Company in 2019
Figure 47. India Irritable Bowel Syndrome with Constipation Drugs Sales Market Share by Type in 2019
Figure 48. India Irritable Bowel Syndrome with Constipation Drugs Sales Market Share by Application in 2019
Figure 49. Key Raw Materials Price Trend
Figure 50. Manufacturing Cost Structure of Irritable Bowel Syndrome with Constipation Drugs
Figure 51. Manufacturing Process Analysis of Irritable Bowel Syndrome with Constipation Drugs
Figure 52. Irritable Bowel Syndrome with Constipation Drugs Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Porter's Five Forces Analysis
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
下痢同伴過敏性腸症候群（IBS-D）治療薬の世界市場レポート2020 Rifaximin (Xifaxan) is an antibiotic medication for IBS-D that works by reducing or altering gut bacteria, and it can improve symptoms of bloating and diarrhea after a 10 to 14 day course of treatment. Some patients require retreatment at higher doses for symptom relief. Market Analysis and Insights…- 過敏性腸症候群（IBS）の世界市場レポート2020 Irritable bowel syndrome (IBS) is defined as recurrent abdominal pain or discomfort that occurs in association with altered bowel habits over a period of at least 3 months. The disorder is classified into three main subtypes, according to the predominant bowel habits presented: constipation-predomin…
- オピオイド誘発性便秘の世界市場レポート2020 Although opioids are very effective for treating and managing pain, their use frequently results in opioid-induced constipation (OIC). Treatment options for OIC may be as simple as changing diet or as complicated as requiring several medicines and laxatives. In the last several years, global market …
- 便秘治療薬の世界市場レポート2020 Market Analysis and Insights: Global Constipation Treatment Drug Market The global Constipation Treatment Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Constipation Treatment Drug Scope and Market Size The global…
- 麻酔薬・鎮痛薬の世界市場レポート2020 Market Analysis and Insights: Global Anaesthetic Drugs and Pain Drugs Market The global Anaesthetic Drugs and Pain Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Anaesthetic Drugs and Pain Drugs Scope and Market …